Effect of Levonorgestrel Intrauterine System on Hemoglobin Level

Effect of Levonorgestrel Intrautrine System on Hemoglobin Level and Iron Profile on Women Requiring Contraception

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06935968

Enrollment

100

Registered

2025-04-20

Start date

2025-05-01

Completion date

2026-07-31

Last updated

2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemoglobin; Deficiency

Brief summary

To study the effect of LNG-IUS on improving iron status in reproductive-aged women presenting for contraception.

Detailed description

Women come to family planning clinic to insert levonorgestrel intrautrine system and take a blood sample from her to analyse hemoglobin level

Interventions

DEVICELevonorgestrel intrautrine system

Insertion of levonorgestrel intrautrine system and take a blood sample from the women to analyse it

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

1. The study will include married women attending the outpatient clinics of the forementioned health facilities for contraception counseling 2. Age between 18 and 45 years 3. Women who choose LNG\_IUS for contraception 4. Any parity including nulliparous

Exclusion criteria

* 1.Women with any inherited hemoglobinopathy (thalassemia, sickle cell anemia) or acquired hemolytic anemia 2.Women with sever iron deficiency anemia requiring immediate treatment 3.Women with any contraindication to Mirena insertion (pelvic inflammatory disease, cervical or vaginal infection, cervical cancer) 4. Any uterine abnormality making LNG\_IUS insertion difficult (septate uterus or fibroid distorting the cavity) 5. Women within 6 months of delivery

Design outcomes

Primary

Measure	Time frame	Description
Change of blood haemoglobin level from time of insertion to 6 months after insertion	6 months	To know the effect of LNG-IUDs on hemoglobin level after insertion

Secondary

Measure	Time frame	Description
Change of serum ferritin level from time of insertion to 6 months after insertionPrevalence of iron deficiency and iron deficiency anemia in women requiring contraception in our community	6 months	To know the effect of LNG-IUDs in serum ferritin

Contacts

Primary ContactMariam Melad

mariomamelad8@gmail.com01020214925

Backup ContactEssam eldeen Rashad

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026